Tirzepatide 5 mg
- Concentration: 5 mg per vial
- Pack Size: Single vial (lyophilized powder)
- Manufacturer: Peptide Sciences USA
- Brand Name: Tirzepatide
- Molecular Formula: C225H348N56O67
- Molecular Weight: 4813.5 g/mol
- Synonyms: LY3298176, Dual Incretin Agonist Peptide
Tirzepatide 5 mg is an innovative dual incretin receptor agonist peptide under investigation for its potential to regulate body weight, improve insulin sensitivity, and suppress appetite. Developed by Peptide Sciences USA, this research-grade injectable compound targets both GLP-1 and GIP receptors, mimicking two naturally occurring gut hormones that play key roles in metabolic regulation.
Mechanism of Action
Tirzepatide acts as a dual agonist of the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. By activating these two pathways simultaneously, it enhances insulin secretion, suppresses glucagon release, and slows gastric emptying. These combined effects contribute to reduced food intake, improved glucose tolerance, and weight loss in preclinical models.
GLP-1 receptor activation leads to increased satiety and appetite suppression, while GIP receptor stimulation amplifies the insulin response to glucose. Tirzepatide's synergistic mechanism makes it a subject of interest in obesity, metabolic syndrome, and Type 2 diabetes research. Its long-acting formulation allows for sustained receptor engagement, often with once-weekly dosing protocols in research settings.
Key Features & Benefits
- Dual Receptor Action: Simultaneously targets GLP-1 and GIP receptors for comprehensive metabolic modulation.
- Supports Appetite Control: Reduces hunger and enhances satiety through gut hormone signaling.
- Promotes Fat Loss: Studied for significant reductions in visceral and subcutaneous fat in lab models.
- Enhances Insulin Sensitivity: Improves glycemic balance and insulin response in metabolic research.
- Research-Grade Formulation: High-purity lyophilized peptide from Peptide Sciences USA for laboratory use.
Legal Disclaimer
Disclaimer: Tirzepatide is provided exclusively for laboratory research and preclinical studies. It is not intended for human consumption or therapeutic use. It has not been evaluated by the FDA and must be handled by qualified research professionals in accordance with local regulations.
Frequently Asked Questions
Tirzepatide is a synthetic peptide that functions as a dual GLP-1 and GIP receptor agonist, studied for its effects on appetite, insulin regulation, and weight reduction.
It mimics gut hormones that influence insulin release, glucagon suppression, and satiety signals, making it a powerful tool in metabolic and obesity research models.
In preclinical studies, appetite suppression effects are often observed within hours to days of administration, with consistent results over multi-week protocols.
In research settings, Tirzepatide has shown a favorable safety profile, though side effects such as nausea or gastrointestinal discomfort have been noted in dose-dependent studies.
Tirzepatide is typically administered via subcutaneous injection in laboratory models. Specific injection protocols should follow approved research methodologies.
Related Products
- Active Substance: Tirzepatide
- Concentration: 5 mg per vial
- Pack Size: Lyophilized injectable vial
- Manufacturer: Dragon Pharma
- Brand Name: Tirze-Pep
- Molecular Formula: C225H348N56O64
- Molecular Weight: 4813.5 g/mol
- Synonyms: LY3298176, GLP-1/GIP dual agonist
- Active Substance: Epitalon
- Concentration: 50 mg per vial
- Pack Size: Single vial (lyophilized powder)
- Manufacturer: Peptide Sciences USA
- Brand Name: Epitalon
- Molecular Formula: C14H22N4O9
- Molecular Weight: 390.35 g/mol
- Sequence: Ala-Glu-Asp-Gly
- Synonyms: Epithalon, AEDG, Epithalamin analog
- Active Substance: Proxofim (FOXO4-D-Retro-Inverso)
- Concentration: 10 mg per vial
- Pack Size: Single vial (lyophilized powder)
- Manufacturer: Peptide Sciences USA
- Brand Name: Proxofim
- Molecular Formula: C228H388N86O64
- Molecular Weight: 5358.05 g/mol
- Sequence: H-D-Leu-D-Thr-D-Leu-D-Arg-D-Lys-D-Glu-D-Pro-D-Ala-D-Ser-D-Glu-D-Ile-D-Ala-D-Gln-D-Ser-D-Ile-D-Leu-D-Glu-D-Ala-D-Tyr-D-Ser-D-Gln-D-Asn-D-Gly-D-Trp-D-Ala-D-Asn-D-Arg-D-Arg-D-Ser-D-Gly-D-Gly-D-Lys-D-Arg-D-Pro-D-Pro-D-Pro-D-Arg-D-Arg-D-Arg-D-Gln-D-Arg-D-Arg-D-Lys-D-Lys-D-Arg-D-Gly-OH
- Synonyms: Forkhead box protein O4 D-Retro-Inverso, FOXO4a, AFX, AFX1, MLLT7
- Active Substance: HGH Fragment 176-191 (6 mg), Modified GRF (CJC-1295 No DAC, 3 mg), Ipamorelin (3 mg)
- Concentration: 12 mg per vial (6 mg HGH Fragment 176-191 + 3 mg Modified GRF + 3 mg Ipamorelin)
- Pack Size: Single vial (lyophilized powder)
- Manufacturer: Peptide Sciences USA
- Brand Name: Peptide Blend
- Molecular Formula (HGH Fragment 176-191): C78H125N24O24S2
- Molecular Weight (HGH Fragment 176-191): 1817.12 g/mol
- Sequence (HGH Fragment 176-191): Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe
- Molecular Formula (Modified GRF): C152H252N44O42
- Molecular Weight (Modified GRF): 3367.97 g/mol
- Sequence (Modified GRF): H-Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH2
- Molecular Formula (Ipamorelin): C38H49N9O5
- Molecular Weight (Ipamorelin): 711.85 g/mol
- Sequence (Ipamorelin): Aib-His-D-2-Nal-D-Phe-Lys-NH2
- Synonyms: HGH Fragment 176-191 (AOD9604), Modified GRF (CJC-1295 No DAC), Ipamorelin (GHRP, Ghrelin mimetic)
- Active Substance: HGH Fragment 176-191 (6 mg), CJC1295 No DAC (3 mg), Ipamorelin (3 mg)
- Concentration: 12 mg per vial (6 mg HGH Fragment 176-191 + 3 mg CJC1295 + 3 mg Ipamorelin)
- Pack Size: Single vial (lyophilized powder)
- Manufacturer: Peptide Sciences USA
- Brand Name: Peptide Blend
- Molecular Formula (HGH Fragment 176-191): C78H125N24O24S2
- Molecular Weight (HGH Fragment 176-191): 1817.12 g/mol
- Sequence (HGH Fragment 176-191): Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe
- Molecular Formula (CJC1295 No DAC): C152H252N44O42
- Molecular Weight (CJC1295 No DAC): 3367.97 g/mol
- Sequence (CJC1295 No DAC): H-Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH2
- Molecular Formula (Ipamorelin): C38H49N9O5
- Molecular Weight (Ipamorelin): 711.85 g/mol
- Sequence (Ipamorelin): Aib-His-D-2-Nal-D-Phe-Lys-NH2
- Synonyms: HGH Fragment 176-191 (AOD9604), CJC1295 No DAC (Mod GRF), Ipamorelin (GHRP, Ghrelin mimetic)